Home
>
US Stocks
>
Castle Biosciences Inc
Castle Biosciences Inc
CSTL

Castle Biosciences Inc (CSTL)

$60.623.93%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$62
Today Low/High$60.33 / $62.05
52 Week Low/High$43.37 / $107.69
Market Cap$1.59B

Company Details

Castle Biosciences is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq), cutaneous squamous cell carcinoma (DecisionDx®-SCC), suspicious pigmented lesions (DecisionDx® DiffDx™-Melanoma) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq).Castle also has active research and development programs for tests in other dermatologic diseases with high clinical need. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona.
OrganisationCastle Biosciences Inc
Employees200
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Castle Biosciences Inc (CSTL) share price today?

Can Indians buy Castle Biosciences Inc (CSTL) shares?

How can I buy Castle Biosciences Inc (CSTL) shares from India?

Can Fractional shares of Castle Biosciences Inc (CSTL) be purchased?

What are the documents required to start investing in Castle Biosciences Inc (CSTL) stocks?

We are a SEBI registered investement advisor